Each year, more than 30 million people globally receive surgery to correct cataracts. As many people age, the crystalline ...

LENZ Therapeutics' aceclidine outshines Vuity for presbyopia with better safety and duration. Click for LENZ's market potential and revenue growth forecast.

In other recent news, Opus Genetics, Inc. announced positive results from its Phase 3 LYNX-2 clinical trial for Phentolamine Ophthalmic Solution 0.75%, aimed at improving night vision for patients ...

Presbyopia affects approximately 128 million Americans and over 2 billion people worldwide, with numbers expected to increase as populations age. Despite the significant market opportunity, Opus ...

Topline data were announced from a phase 3 trial evaluating MR-141 (phentolamine ophthalmic solution 0.75%) for the treatment of presbyopia.

This segment is sponsored by Johnson & Johnson.In a breakthough in vision technology, there is now a first-of-its kind, daily ...

Johnson & Johnson is launching what it describes as the first and only daily disposable, multifocal and toric contact lens for people who have both astigmatism and presbyopia, where n | J&J said ...

This is an overview of systematic reviews to evaluate the visual outcomes of different presbyopia correcting intraocular lens ...

Presbyopia is a ubiquitous visual disability of the aging eye, affecting an estimated 1.04 billion people globally. [1] Given the prevalence, an increasing emphasis has been placed on the ...

A second phase 3 pivotal clinical trial investigating phentolamine ophthalmic solution 0.75% for the treatment of presbyopia met its primary and key secondary endpoints, according to a press ...

Presbyopia is an ophthalmic disorder that involves the progressive loss of ability to focus on close objects that results in blurred near vision, difficulty seeing in dim light, and eye strain.

Get here detailed syllabus of ICSE for Class 10 for the new academic session 2025-2026. Download the Biology PDFs to know the ...